Olfactory Ensheathing Cell Transplantation in Experimental Spinal Cord Injury: Effect size and Reporting Bias of 62 Experimental Treatments: A Systematic Review and Meta-Analysis

PLoS Biology

Volumn 14, Issue 5, 2016, Pages

  Watzlawick, Ralf ^a,b   Rind, Julian ^a   Sena, Emily S ^c,d   Brommer, Benedikt ^a,e   Zhang, Tian ^a   Kopp, Marcel A ^a   Dirnagl, Ulrich ^a,f   Macleod, Malcolm R ^c   Howells, David W ^d,g   Schwab, Jan M ^a,h  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^g UNIVERSITY OF TASMANIA   (Australia)

^h THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TRANSPLANTATION; CLINICAL EFFECTIVENESS; EXPERIMENTAL SPINAL CORD INJURY; INFORMATION PROCESSING; LOCOMOTION; NONHUMAN; OLFACTORY ENSHEATHING CELL TRANSPLANTATION; OUTCOME ASSESSMENT; PUBLISHING; SAFETY; STUDY DESIGN; SYSTEMATIC ERROR; ADVERSE EFFECTS; ANIMAL; CYTOLOGY; DISEASE MODEL; META ANALYSIS; OLFACTORY BULB; PROCEDURES; SPINAL CORD INJURIES; TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; OLFACTORY BULB; PUBLICATION BIAS; SPINAL CORD INJURIES; TREATMENT OUTCOME;

EID: 84971602761     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1002468     Document Type: Article

References (41)

1. Ruff CA, Wilcox JT, Fehlings MG, Cell-based transplantation strategies to promote plasticity following spinal cord injury. Experimental neurology. 2012;235(1):78–90. doi: 10.1016/j.expneurol.2011.02.01021333647.
2. Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, Hill CE, Sparling JS, Plemel JR, et al. A systematic review of cellular transplantation therapies for spinal cord injury. Journal of neurotrauma. 2011;28(8):1611–82. doi: 10.1089/neu.2009.117720146557; PubMed Central PMCID: PMCPmc3143488.
3. Thuret S, Moon LD, Gage FH, Therapeutic interventions after spinal cord injury. Nature reviews Neuroscience. 2006;7(8):628–43. doi: 10.1038/nrn195516858391.
4. Ramon-Cueto A, Nieto-Sampedro M, Regeneration into the spinal cord of transected dorsal root axons is promoted by ensheathing glia transplants. Experimental neurology. 1994;127(2):232–44. doi: 10.1006/exnr.1994.10998033963.
5. Li Y, Field PM, Raisman G, Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science (New York, NY). 1997;277(5334):2000–2. 9302296.
6. Roet KC, Verhaagen J, Understanding the neural repair-promoting properties of olfactory ensheathing cells. Experimental neurology. 2014;261c:594–609. doi: 10.1016/j.expneurol.2014.05.00724842489.
7. Raisman G, Li Y, Repair of neural pathways by olfactory ensheathing cells. Nature reviews Neuroscience. 2007;8(4):312–9. doi: 10.1038/nrn209917342173.
8. Barnett SC, Riddell JS, Olfactory ensheathing cell transplantation as a strategy for spinal cord repair—what can it achieve?Nature clinical practice Neurology. 2007;3(3):152–61. doi: 10.1038/ncpneuro044717342191.
9. Richter MW, Roskams AJ, Olfactory ensheathing cell transplantation following spinal cord injury: hype or hope?Experimental neurology. 2008;209(2):353–67. doi: 10.1016/j.expneurol.2007.06.01117643431.
10. Toft A, Scott DT, Barnett SC, Riddell JS, Electrophysiological evidence that olfactory cell transplants improve function after spinal cord injury. Brain: a journal of neurology. 2007;130(Pt 4):970–84. doi: 10.1093/brain/awm04017438017.
11. Lu J, Feron F, Mackay-Sim A, Waite PM, Olfactory ensheathing cells promote locomotor recovery after delayed transplantation into transected spinal cord. Brain: a journal of neurology. 2002;125(Pt 1):14–21. 11834589.
12. Lopez-Vales R, Fores J, Navarro X, Verdu E, Chronic transplantation of olfactory ensheathing cells promotes partial recovery after complete spinal cord transection in the rat. Glia. 2007;55(3):303–11. doi: 10.1002/glia.2045717096411.
13. Ziegler MD, Hsu D, Takeoka A, Zhong H, Ramon-Cueto A, Phelps PE, et al. Further evidence of olfactory ensheathing glia facilitating axonal regeneration after a complete spinal cord transection. Experimental neurology. 2011;229(1):109–19. doi: 10.1016/j.expneurol.2011.01.00721272578; PubMed Central PMCID: PMCPmc3085566.
14. Bregman BS, Kunkel-Bagden E, Reier PJ, Dai HN, McAtee M, Gao D, Recovery of function after spinal cord injury: mechanisms underlying transplant-mediated recovery of function differ after spinal cord injury in newborn and adult rats. Experimental neurology. 1993;123(1):3–16. doi: 10.1006/exnr.1993.11368405277.
15. Higgins JP, Thompson SG, Deeks JJ, Altman DG, Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60. doi: 10.1136/bmj.327.7414.55712958120; PubMed Central PMCID: PMC192859.
16. Basso DM, Beattie MS, Bresnahan JC, A sensitive and reliable locomotor rating scale for open field testing in rats. Journal of neurotrauma. 1995;12(1):1–21. 7783230.
17. Steward O, Popovich PG, Dietrich WD, Kleitman N, Replication and reproducibility in spinal cord injury research. Experimental neurology. 2012;233(2):597–605. doi: 10.1016/j.expneurol.2011.06.01722078756.
18. Steward O, Sharp K, Selvan G, Hadden A, Hofstadter M, Au E, et al. A re-assessment of the consequences of delayed transplantation of olfactory lamina propria following complete spinal cord transection in rats. Experimental neurology. 2006;198(2):483–99. doi: 10.1016/j.expneurol.2005.12.03416494866.
19. Goodman SN, A comment on replication, p-values and evidence. Statistics in medicine. 1992;11(7):875–9. 1604067.
20. Gorroochurn P, Hodge SE, Heiman GA, Durner M, Greenberg DA, Non-replication of association studies: "pseudo-failures" to replicate?Genetics in medicine: official journal of the American College of Medical Genetics. 2007;9(6):325–31. doi: 10.1097GIM.0b013e3180676d79 17575498.
21. Aberegg SK, Richards DR, O'Brien JM, Delta inflation: a bias in the design of randomized controlled trials in critical care medicine. Crit Care. 2010;14(2):R77. doi: 10.1186/cc899020429873; PubMed Central PMCID: PMCPMC2887200.
22. Howells DW, Sena ES, Macleod MR, Bringing rigour to translational medicine. Nat Rev Neurol. 2014;10(1):37–43. doi: 10.1038/nrneurol.2013.23224247324.
23. Curt A, The translational dialogue in spinal cord injury research. Spinal cord. 2012;50(5):352–7. doi: 10.1038/sc.2011.11322064661.
24. Antonic A, Sena ES, Lees JS, Wills TE, Skeers P, Batchelor PE, et al. Stem cell transplantation in traumatic spinal cord injury: a systematic review and meta-analysis of animal studies. PLoS Biol. 2013;11(12):e1001738. doi: 10.1371/journal.pbio.100173824358022; PubMed Central PMCID: PMCPmc3866091.
25. Sena ES, Currie GL, McCann SK, Macleod MR, Howells DW, Systematic reviews and meta-analysis of preclinical studies: why perform them and how to appraise them critically. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. 2014;34(5):737–42. doi: 10.1038/jcbfm.2014.2824549183; PubMed Central PMCID: PMCPmc4013765.
26. Watzlawick R, Sena ES, Dirnagl U, Brommer B, Kopp MA, Macleod MR, et al. Effect and reporting bias of RhoA/ROCK-blockade intervention on locomotor recovery after spinal cord injury: a systematic review and meta-analysis. JAMA neurology. 2014;71(1):91–9. doi: 10.1001/jamaneurol.2013.468424297045.
27. Kwon BK, Okon EB, Tsai E, Beattie MS, Bresnahan JC, Magnuson DK, et al. A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury. Journal of neurotrauma. 2011;28(8):1525–43. doi: 10.1089/neu.2010.129620507235; PubMed Central PMCID: PMCPmc3143387.
28. Jani HR, Raisman G, Ensheathing cell cultures from the olfactory bulb and mucosa. Glia. 2004;47(2):130–7. doi: 10.1002/glia.2003815185392.
29. Mayeur A, Duclos C, Honore A, Gauberti M, Drouot L, do Rego JC, et al. Potential of olfactory ensheathing cells from different sources for spinal cord repair. PLoS ONE. 2013;8(4):e62860. Epub 2013/05/03. doi: 10.1371/journal.pone.006286023638158; PubMed Central PMCID: PMCPmc3634744.
30. Mackay-Sim A, St John JA, Olfactory ensheathing cells from the nose: clinical application in human spinal cord injuries. Experimental neurology. 2011;229(1):174–80. doi: 10.1016/j.expneurol.2010.08.02520832402.
31. Radojicic M, Reier PJ, Steward O, Keirstead HS, Septations in chronic spinal cord injury cavities contain axons. Experimental neurology. 2005;196(2):339–41. doi: 10.1016/j.expneurol.2005.08.00916153640.
32. Guest J, Benavides F, Padgett K, Mendez E, Tovar D, Technical aspects of spinal cord injections for cell transplantation. Clinical and translational considerations. Brain research bulletin. 2011;84(4–5):267–79. Epub 2010/11/20. doi: 10.1016/j.brainresbull.2010.11.00721087657.
33. Piltti KM, Avakian SN, Funes GM, Hu A, Uchida N, Anderson AJ, et al. Transplantation dose alters the dynamics of human neural stem cell engraftment, proliferation and migration after spinal cord injury. Stem cell research. 2015;15(2):341–53. doi: 10.1016/j.scr.2015.07.00126298025; PubMed Central PMCID: PMCPmc4600655.
34. Li L, Adnan H, Xu B, Wang J, Wang C, Li F, et al. Effects of transplantation of olfactory ensheathing cells in chronic spinal cord injury: a systematic review and meta-analysis. European spine journal: official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 2015;24(5):919–30. doi: 10.1007/s00586-014-3416-625001890.
35. Dlouhy BJ, Awe O, Rao RC, Kirby PA, Hitchon PW, Autograft-derived spinal cord mass following olfactory mucosal cell transplantation in a spinal cord injury patient: Case report. Journal of neurosurgery Spine. 2014;21(4):618–22. doi: 10.3171/2014.5.spine1399225002238.
36. Ferguson AR, Hook MA, Garcia G, Bresnahan JC, Beattie MS, Grau JW, A simple post hoc transformation that improves the metric properties of the BBB scale for rats with moderate to severe spinal cord injury. Journal of neurotrauma. 2004;21(11):1601–13. doi: 10.1089/neu.2004.21.160115684652.
37. Simonsohn U, Nelson LD, Simmons JP, p-Curve and Effect Size: Correcting for Publication Bias Using Only Significant Results. Perspect Psychol Sci. 2014;9(6):666–81. doi: 10.1177/174569161455398826186117.
38. Vesterinen HM, Sena ES, Egan KJ, Hirst TC, Churolov L, Currie GL, et al. Meta-analysis of data from animal studies: A practical guide. Journal of neuroscience methods. 2014;221:92–102. doi: 10.1016/j.jneumeth.2013.09.01024099992.
39. Leenaars M, Hooijmans CR, van Veggel N, ter Riet G, Leeflang M, Hooft L, et al. A step-by-step guide to systematically identify all relevant animal studies. Laboratory animals. 2012;46(1):24–31. doi: 10.1258/la.2011.01108722037056; PubMed Central PMCID: PMCPmc3265183.
40. Macleod MR, O'Collins T, Howells DW, Donnan GA, Pooling of animal experimental data reveals influence of study design and publication bias. Stroke; a journal of cerebral circulation. 2004;35(5):1203–8. doi: 10.1161/01.str.0000125719.25853.2015060322.
41. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG, Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8(6):e1000412. Epub 2010/07/09. doi: 10.1371/journal.pbio.100041220613859; PubMed Central PMCID: PMCPmc2893951.